Abstract 4616: Establishment of a metastatic orthotopic model of pancreatic ductal adenocarcinoma (PDAC) for drug development

Ductal adenocarcinoma of the pancreas (PDAC) has the worst survival prognosis ( in vivo. Citation Format: Justyna Zdrojewska, Jenni H.E. Maki-Jouppila, Jussi M. Halleen, Jenni Bernoulli. Establishment of a metastatic orthotopic model of pancreatic ductal adenocarcinoma (PDAC) for drug development [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4616.